326 results on '"Ben-David, Uri"'
Search Results
2. Aneuploidy as a driver of human cancer
3. Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
4. Machine-learning analysis reveals an important role for negative selection in shaping cancer aneuploidy landscapes
5. CKAP5 stabilizes CENP-E at kinetochores by regulating microtubule-chromosome attachments
6. Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q
7. Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
8. Acute expression of human APOBEC3B in mice results in RNA editing and lethality
9. Short-term molecular consequences of chromosome mis-segregation for genome stability
10. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling
11. Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage
12. The cGAS-STING, p38 MAPK, and p53 pathways link genome instability to accelerated cellular senescence in ATM-deficient murine lung fibroblasts.
13. Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta Cells
14. Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division
15. Publisher Correction: DNA-based copy number analysis confirms genomic evolution of PDX models
16. DNA-based copy number analysis confirms genomic evolution of PDX models
17. Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy
18. Abstract B003: Identification of novel genes that regulate aneuploidy tolerance by attenuating aneuploidy-induced stresses
19. Abstract PR008: Targeting mechanisms of dosage compensation to selectively kill aneuploid cancer cells
20. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
21. This title is unavailable for guests, please login to see more information.
22. This title is unavailable for guests, please login to see more information.
23. Genome doubling causes double trouble
24. Chromosome 7 to the rescue: overcoming chromosome 10 loss in gliomas
25. Aneuploid senescent cells activate NF-κB to promote their immune clearance by NK cells
26. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
27. Context is everything: aneuploidy in cancer
28. FOXM1 repression increases mitotic death upon antimitotic chemotherapy through BMF upregulation
29. CDC20 determines the sensitivity to spindle assembly checkpoint (SAC) inhibitors
30. A compendium of Amplification-Related Gain Of Sensitivity (ARGOS) genes in human cancer
31. Genomic evolution of cancer models: perils and opportunities
32. Genetic and transcriptional evolution alters cancer cell line drug response
33. Supplementary figure 1 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
34. Data from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
35. Supplementary figure 2 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
36. Supplementary table 1 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
37. Supplementary table 2 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
38. Supplementary table 3 from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
39. Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
40. Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations
41. Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations
42. Computationally Engineered CRISPR-SpyCas9 High-Fidelity Variants with Improved Specificity and Reduced Non-specific DNA Damage
43. Supplementary Figures S6 - S10 from Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
44. Supplementary Table S1 from Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
45. Supplementary Figure Legends from Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
46. Data from Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
47. Supplementary Methods from Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
48. Genomic instability, driver genes and cell selection: Projections from cancer to stem cells
49. Patient-derived xenografts undergo mouse-specific tumor evolution
50. Supplementary Table 1 from Landscape of Genomic Alterations in Pituitary Adenomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.